MX2015016400A - Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona. - Google Patents

Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.

Info

Publication number
MX2015016400A
MX2015016400A MX2015016400A MX2015016400A MX2015016400A MX 2015016400 A MX2015016400 A MX 2015016400A MX 2015016400 A MX2015016400 A MX 2015016400A MX 2015016400 A MX2015016400 A MX 2015016400A MX 2015016400 A MX2015016400 A MX 2015016400A
Authority
MX
Mexico
Prior art keywords
dihydro
compounds
isoindol
isoquinoline
new
Prior art date
Application number
MX2015016400A
Other languages
English (en)
Other versions
MX366678B (es
Inventor
Rainer E Martin
Yongfu Liu
Lisha Wang
Johannes Aebi
Kurt Amrein
Benoit Hornsperger
Bernd Kuhn
Hans P Maerki
Alexander V Mayweg
Xuefei Tan
Mingwei Zhou
Wenming Chen
Dongbo Li
Wu Jun
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2015016400A publication Critical patent/MX2015016400A/es
Publication of MX366678B publication Critical patent/MX366678B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención proporciona nuevos compuestos que tienen la fórmula general (I) (ver Fórmula) en la que R1, R2, R3, R4 R5, R6, R7, R8, R9, R10 R11, R12, R13, R14, A, B, m, n y p son tal como se describe en el presente documento, composiciones que incluyen los compuestos y métodos de uso de los compuestos.
MX2015016400A 2013-05-27 2014-05-26 Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona. MX366678B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2013076276 2013-05-27
PCT/EP2014/060784 WO2014191336A1 (en) 2013-05-27 2014-05-26 New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

Publications (2)

Publication Number Publication Date
MX2015016400A true MX2015016400A (es) 2016-04-11
MX366678B MX366678B (es) 2019-07-19

Family

ID=50841775

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016400A MX366678B (es) 2013-05-27 2014-05-26 Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.

Country Status (13)

Country Link
US (1) US9505742B2 (es)
EP (2) EP3719019B1 (es)
JP (1) JP6581970B2 (es)
KR (1) KR102217285B1 (es)
CN (1) CN105308045B (es)
AR (1) AR096423A1 (es)
CA (1) CA2911473C (es)
ES (1) ES2804271T3 (es)
HK (1) HK1214258A1 (es)
MX (1) MX366678B (es)
RU (1) RU2689421C2 (es)
TW (1) TWI642668B (es)
WO (1) WO2014191336A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA122061C2 (uk) * 2014-10-08 2020-09-10 Ф. Хоффманн-Ля Рош Аг Похідні спіродіаміну як інгібітори альдостеронсинтази
CN104529854B (zh) * 2015-01-14 2016-10-05 武汉金联药业有限公司 一种取代氮杂环丁烷类医药中间体化合物的合成方法
CN107325112A (zh) * 2017-06-05 2017-11-07 毛琳琳 具有抗肝炎活性的2H‑苯并[b][1,4]噁嗪并吡唑化合物的制备方法
CA3078769A1 (en) 2017-10-27 2019-05-02 Boehringer Ingelheim International Gmbh Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors
WO2022034146A1 (en) 2020-08-13 2022-02-17 Boehringer Ingelheim International Gmbh Treatment of cognitive impairement associated with schizophrenia
WO2023063851A1 (en) * 2021-10-13 2023-04-20 «Target Medicals» Limited Liability Company Inhibitors of human aldosterone synthase (cyp11b2)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI400232B (zh) * 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
EP2627648A1 (en) * 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
WO2013037779A1 (en) * 2011-09-15 2013-03-21 F. Hoffmann-La Roche Ag New dihydroquinoline-2-one derivatives
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
CA2850700C (en) * 2011-11-30 2019-11-12 F. Hoffmann-La Roche Ag New bicyclic dihydroisoquinoline-1-one derivatives

Also Published As

Publication number Publication date
MX366678B (es) 2019-07-19
EP3719019B1 (en) 2022-01-19
TW201504237A (zh) 2015-02-01
TWI642668B (zh) 2018-12-01
BR112015029696A2 (pt) 2017-07-25
CN105308045B (zh) 2017-05-17
RU2015150614A (ru) 2017-07-03
CA2911473A1 (en) 2014-12-04
JP6581970B2 (ja) 2019-09-25
CN105308045A (zh) 2016-02-03
US20160075686A1 (en) 2016-03-17
US9505742B2 (en) 2016-11-29
KR20160014669A (ko) 2016-02-11
EP3004089A1 (en) 2016-04-13
AR096423A1 (es) 2015-12-30
KR102217285B1 (ko) 2021-02-22
CA2911473C (en) 2022-05-03
JP2016520105A (ja) 2016-07-11
WO2014191336A1 (en) 2014-12-04
EP3719019A1 (en) 2020-10-07
ES2804271T3 (es) 2021-02-05
RU2689421C2 (ru) 2019-05-28
HK1214258A1 (zh) 2016-07-22
EP3004089B1 (en) 2020-05-06

Similar Documents

Publication Publication Date Title
PH12017500658B1 (en) Spirodiamine derivatives as aldosterone synthase inhibitors
PH12017501825A1 (en) Bicyclic quinazolinone derivatives
IN2015DN00960A (es)
MX2015001099A (es) Nuevos derivados biciclicos de piridina.
PH12014502697A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
PH12016501007A1 (en) Substituted benzamides and methods of use thereof
MY169043A (en) New dihydroquinoline-2-one derivatives
MY186165A (en) New bicyclic dihydroquinoline-2-one derivatives
MX351581B (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen.
EA201401054A1 (ru) N-циклиламиды в качестве нематоцидов
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MY169267A (en) New aryl-quinoline derivatives
MX343225B (es) Nuevos derivados de aril-benzocicloalquil-amida.
MX366678B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
MX2012008141A (es) Compuestos y metodos.
MX2015015010A (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
MX2013005753A (es) Nuevos derivados de biaril amida.
GEP20186893B (en) Pyrazines modulators of gpr6
MX368759B (es) Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona.
MX2015011005A (es) Derivados de dihidorquinolin-2-ona para usarse como inhibidores de aldoesterona sintasa.
MX2016002762A (es) Derivados de fenil-dihidropiridina como inhibidores de aldosterona sintasa.
MX2015009377A (es) Compuestos radiomarcados.
TW201613947A (en) Dinitrosyl iron complexes, uses thereof, and water splitting device using the same

Legal Events

Date Code Title Description
FG Grant or registration